Search Results for "indomethacin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for indomethacin. Results 1 to 10 of 27 total matches.
See also: Indocin, Tivorbex

In Brief: Low-Dose Indomethacin (Tivorbex) for Pain

   
The Medical Letter on Drugs and Therapeutics • Jul 21, 2014  (Issue 1447)
In Brief: Low-Dose Indomethacin (Tivorbex) for Pain ...
The same pharmaceutical company (Iroko) that recently marketed low-dose diclofenac (Zorvolex) for treatment of mild to moderate acute pain1 has now received approval from the FDA to market a low-dose oral formulation of indomethacin (Tivorbex) for the same indication. Tivorbex is available in 20- and 40-mg capsules; conventional immediate-release indomethacin capsules contain 25 mg and 50 mg of the drug.The rationale for this new product is the same as the one offered for Zorvolex: the drug is formulated as submicron particles that increase surface area, leading to faster dissolution and...
Med Lett Drugs Ther. 2014 Jul 21;56(1447):64 |  Show IntroductionHide Introduction

Nabumetone - A New Nsaid

   
The Medical Letter on Drugs and Therapeutics • Apr 17, 1992  (Issue 868)
1600 mg/day, indomethacin 75 to 150 mg/day, or naproxen 500 mg/day had similar therapeutic effects (DJ ...
Nabumetone (Relafen - SmithKline Beecham), a new nonsteroidal anti-inflammatory drug (NSAID), has been approved by the US Food and Drug Administration for treatment of rheumatoid arthritis and osteoarthritis. The drug has been available in the United Kingdom since 1987. The manufacturer claims that nabumetone is as effective as other NSAIDs and causes a relatively low incidence of peptic ulcers.
Med Lett Drugs Ther. 1992 Apr 17;34(868):38-40 |  Show IntroductionHide Introduction

Etodolac

   
The Medical Letter on Drugs and Therapeutics • Aug 23, 1991  (Issue 851)
etodolac twice daily was more effective than 50 mg indomethacin (Indocin, and others) three times daily ...
Etodolac (Lodine - Wyeth-Ayerst), a nonsteroidal anti-inflammatory drug (NSAID) available in Europe for several years, was recently approved by the U.S. Food and Drug Administration for use in osteoarthritis and as a general-purpose analgesic. It has not been approved for treatment of rheumatoid arthritis.
Med Lett Drugs Ther. 1991 Aug 23;33(851):79-80 |  Show IntroductionHide Introduction

Oxaprozin for Arthritis

   
The Medical Letter on Drugs and Therapeutics • Feb 19, 1993  (Issue 890)
approved for once-daily use, and indomethacin is available in an extended-release formulation that can ...
Oxaprozin (Daypro -Searle), a propionic acid-derivative nonsteroidal anti-inflammatory drug (NSAID), has been approved by the US Food and Drug Administration for once-daily treatment of rheumatoid arthritis and osteoarthritis. Some of the NSAIDs previously marketed in the USA are listed in the table on page 16. Ibuprofen, naproxen, fenoprofen, ketoprofen, and flurbiprofen are also propionic acid derivatives. Piroxicam and nabumetone (Medical Letter, 34:38, 1992) are also approved for once-daily use, and indomethacin is available in an extended-release formulation that can be taken once...
Med Lett Drugs Ther. 1993 Feb 19;35(890):15-6 |  Show IntroductionHide Introduction

Diclofenac

   
The Medical Letter on Drugs and Therapeutics • Dec 02, 1988  (Issue 780)
, diclofenac has generally been as effective as aspirin, indomethacin (Indocin; and others), ibuprofen (Motrin ...
Diclofenac sodium (Voltaren - Geigy), a nonsteroidal anti-inflammatory drug (NSAID) available in some countries since 1974, was recently introduced in the USA for treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. It is being promoted as 'The number one prescribed antiarthritic in the world.'
Med Lett Drugs Ther. 1988 Dec 2;30(780):109-11 |  Show IntroductionHide Introduction

Low-Dose Meloxicam (Vivlodex) for Osteoarthritis Pain

   
The Medical Letter on Drugs and Therapeutics • Mar 14, 2016  (Issue 1490)
)3 and Tivorbex (indomethacin),4 two other low-dose NSAIDs available from the same manufacturer ...
The FDA has approved Vivlodex (Iroko), a low-dose formulation of the nonsteroidal anti-inflammatory drug meloxicam (Mobic, and generics), for management of osteoarthritis pain. According to the manufacturer, the new formulation aligns with stronger FDA warnings about the cardiovascular risks of NSAIDs and the recommendation to use the lowest possible doses of these drugs.
Med Lett Drugs Ther. 2016 Mar 14;58(1490):35-6 |  Show IntroductionHide Introduction

Flurbiprofen

   
The Medical Letter on Drugs and Therapeutics • Apr 07, 1989  (Issue 789)
, 100-300 mg per day, has generally been about as effective as aspirin, 3-4 grams per day, indomethacin ...
Flurbiprofen (Ansaid - Upjohn), a nonsteroidal anti-inflammatory drug (NSAID) available in some countries since 1977, was recently approved by the US Food and Drug Administration for treatment of rheumatoid arthritis and osteoarthritis. Flurbiprofen is a fluorinated phenylalkanoic acid derivative structurally related to ibuprofen (Motrin;and others).
Med Lett Drugs Ther. 1989 Apr 7;31(789):31-2 |  Show IntroductionHide Introduction

In Brief: Herbal Warning

   
The Medical Letter on Drugs and Therapeutics • Feb 11, 2008  (Issue 1279)
lovastatin (Mevacor, and others), estrogen, alprazolam (Xanax, and others), indomethacin (Indocin ...
The FDA recently advised health care professionals and consumers not to use a number of dietary supplements found to contain the phosphodiesterase-5 inhibitor sildenafil (Viagra) or an analog of the drug (www.fda.gov). Although the effects of sildenafil may be noticeable (in men), the presence of other, possibly more toxic adulterants in dietary supplements may be more difficult or impossible to detect.Other drugs previously found in dietary supplements have included lovastatin (Mevacor, and others), estrogen, alprazolam (Xanax, and others), indomethacin (Indocin, and others) and warfarin...
Med Lett Drugs Ther. 2008 Feb 11;50(1279):9 |  Show IntroductionHide Introduction

Spironolactone for Heart Failure

   
The Medical Letter on Drugs and Therapeutics • Sep 10, 1999  (Issue 1061)
and counterbalance the hyperkalemic effect of spironolactone. Since indomethacin (Indocin, and others ...
Spironolactone, an aldosterone receptor antagonist, has been FDA-approved for many years for treatment of edema, hypertension and primary hyperaldosteronism. Recently, it was reported to improve morbidity and mortality in patients with severe heart failure.
Med Lett Drugs Ther. 1999 Sep 10;41(1061):81-2 |  Show IntroductionHide Introduction

Update on Glucosamine For Osteoarthritis

   
The Medical Letter on Drugs and Therapeutics • Dec 10, 2001  (Issue 1120)
arthritis and a modest anti-inflammatory effect, much less than that of indomethacin (Indocin, and others ...
Since the last Medical Letter article on glucosamine for osteoarthritis (vol.39, page 91, September 26, 1997), more data have become available. Glucosamine is available in US pharmacies and health food stores as sulfate, hydrochloride or n-acetyl salt.
Med Lett Drugs Ther. 2001 Dec 10;43(1120):111-2 |  Show IntroductionHide Introduction